{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "Nasopharyngeal swabs",
      "Pooling",
      "RT-PCR",
      "SARS-CoV-2",
      "Saliva",
      "TMA"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34364098",
  "DateCompleted": {
    "Year": "2021",
    "Month": "10",
    "Day": "13"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "07",
        "Day": "15"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.diagmicrobio.2021.115478",
      "S0732-8893(21)00171-1"
    ],
    "Journal": {
      "ISSN": "1879-0070",
      "JournalIssue": {
        "Volume": "101",
        "Issue": "3",
        "PubDate": {
          "Year": "2021",
          "Month": "Nov"
        }
      },
      "Title": "Diagnostic microbiology and infectious disease",
      "ISOAbbreviation": "Diagn Microbiol Infect Dis"
    },
    "ArticleTitle": "Testing individual and pooled saliva samples for sars-cov-2 nucleic acid: a prospective study.",
    "Pagination": {
      "StartPage": "115478",
      "MedlinePgn": "115478"
    },
    "Abstract": {
      "AbstractText": [
        "Control of the rapid spread of the SARS-CoV-2 virus requires efficient testing. We collected paired nasopharyngeal swab (NPs) and saliva samples from 303 subjects (52.8% symptomatic) at a drive-through testing center; 18% of whom tested positive. The NPs, salivas and five saliva pools were tested for SARS-CoV-2 RNA using the Aptima\u2122 assay and a laboratory-developed test (LDT) on the Panther-Fusion\u2122 Hologic\u00ae platform. The saliva sensitivity was 80% (LDT) and 87.5% (Aptima\u2122) whereas that of NPs was 96.4% in both assays. The pooled saliva sensitivity of 72.7% (LDT) and 75% (Aptima\u2122) was not significantly different of that of individual saliva testing. Saliva specimens appear to be suitable for sensitive non-invasive assays to detect SARS-CoV-2 nucleic acid; pooling them for a single test will improve laboratory throughput."
      ],
      "CopyrightInformation": "Copyright \u00a9 2021 Elsevier Inc. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "CHU Toulouse, H\u00f4pital Purpan, Virology Laboratory, France; Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM UMR1291 - CNRS UMR5051, Toulouse, France; Department of Virology, Universit\u00e9 Toulouse III Paul-Sabatier, Toulouse, France. Electronic address: migueres.m@chu-toulouse.fr."
          }
        ],
        "LastName": "Migueres",
        "ForeName": "Marion",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "CHU Toulouse, H\u00f4pital Purpan, Virology Laboratory, France; Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM UMR1291 - CNRS UMR5051, Toulouse, France; Department of Virology, Universit\u00e9 Toulouse III Paul-Sabatier, Toulouse, France."
          }
        ],
        "LastName": "Vellas",
        "ForeName": "Camille",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "CHU Toulouse, H\u00f4pital Purpan, Virology Laboratory, France; Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM UMR1291 - CNRS UMR5051, Toulouse, France; Department of Virology, Universit\u00e9 Toulouse III Paul-Sabatier, Toulouse, France."
          }
        ],
        "LastName": "Abravanel",
        "ForeName": "Florence",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "CHU Toulouse, H\u00f4pital Purpan, Virology Laboratory, France."
          }
        ],
        "LastName": "Da Silva",
        "ForeName": "Isabelle",
        "Initials": "I"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "CHU Toulouse, H\u00f4pital Purpan, Virology Laboratory, France."
          }
        ],
        "LastName": "Dimeglio",
        "ForeName": "Chlo\u00e9",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "CHU Toulouse, H\u00f4pital Purpan, Virology Laboratory, France."
          }
        ],
        "LastName": "Ferrer",
        "ForeName": "Venicia",
        "Initials": "V"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "CHU Toulouse, H\u00f4pital Purpan, Virology Laboratory, France; Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM UMR1291 - CNRS UMR5051, Toulouse, France; Department of Virology, Universit\u00e9 Toulouse III Paul-Sabatier, Toulouse, France."
          }
        ],
        "LastName": "Raymond",
        "ForeName": "St\u00e9phanie",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "CHU Toulouse, H\u00f4pital Purpan, Virology Laboratory, France."
          }
        ],
        "LastName": "Mansuy",
        "ForeName": "Jean-Michel",
        "Initials": "JM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "CHU Toulouse, H\u00f4pital Purpan, Virology Laboratory, France; Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM UMR1291 - CNRS UMR5051, Toulouse, France; Department of Virology, Universit\u00e9 Toulouse III Paul-Sabatier, Toulouse, France."
          }
        ],
        "LastName": "Izopet",
        "ForeName": "Jacques",
        "Initials": "J"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Diagn Microbiol Infect Dis",
    "NlmUniqueID": "8305899",
    "ISSNLinking": "0732-8893"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "RNA, Viral"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "diagnosis",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "virology"
      ],
      "DescriptorName": "Nasopharynx"
    },
    {
      "QualifierName": [
        "isolation & purification"
      ],
      "DescriptorName": "RNA, Viral"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Reverse Transcriptase Polymerase Chain Reaction"
    },
    {
      "QualifierName": [
        "genetics",
        "isolation & purification"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "virology"
      ],
      "DescriptorName": "Saliva"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Sensitivity and Specificity"
    }
  ]
}